[HTML][HTML] Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance
S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - mdpi.com
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance.
S Karakonstantis, M Rousaki, EI Kritsotakis - 2022 - cabidigitallibrary.org
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - search.proquest.com
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance
S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - eprints.whiterose.ac.uk
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance.
S Karakonstantis, M Rousaki… - Antibiotics (2079 …, 2022 - search.ebscohost.com
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
[PDF][PDF] Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
S Karakonstantis, M Rousaki… - J. Antimicrob …, 2022 - researchgate.net
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
[HTML][HTML] Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
S Karakonstantis, M Rousaki, EI Kritsotakis - Antibiotics, 2022 - ncbi.nlm.nih.gov
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance.
S Karakonstantis, M Rousaki… - Antibiotics (Basel …, 2022 - europepmc.org
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
S Karakonstantis, M Rousaki… - Antibiotics (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
[PDF][PDF] Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance. Antibiotics 2022, 11, 723
S Karakonstantis, M Rousaki, EI Kritsotakis - 2022 - pdfs.semanticscholar.org
Cefiderocol appears promising, as it can overcome most β-lactam resistance mechanisms
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …
(including β-lactamases, porin mutations, and efflux pumps). Resistance is uncommon …